Concepedia

Phillip Friedlander

PF

Statistics

Publications

2

Citations

558

H-Index

2

Active since

2017

Affiliations

The Ohio State University(Current)

Phillip Friedlander is an author at The Ohio State University specializing in cancer immunotherapy, oncology, and immunotherapy for solid tumors.

Publications per year

2017–2019

2

Publications

2

Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · Journal of Clinical Oncology · 2019 · 390 citations · Full text

, , +17

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Mark A. Exley, Phillip Friedlander, Nadia Alatrakchi et al. · Clinical Cancer Research · 2017 · 168 citations · Full text

, , +14

1–2 of 2